AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 154 filers reported holding AMNEAL PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $219,405 | +7.4% | 34,552 | +2.5% | 0.00% | 0.0% |
| Q1 2024 | $204,210 | +11.5% | 33,698 | +11.7% | 0.00% | 0.0% |
| Q4 2023 | $183,156 | +361.9% | 30,174 | +5.8% | 0.00% | – |
| Q1 2023 | $39,655 | -28.2% | 28,529 | +2.7% | 0.00% | -100.0% |
| Q4 2022 | $55,262 | +2.3% | 27,770 | +4.2% | 0.00% | 0.0% |
| Q3 2022 | $54,000 | -35.7% | 26,638 | +1.2% | 0.00% | 0.0% |
| Q2 2022 | $84,000 | -22.9% | 26,312 | +0.3% | 0.00% | 0.0% |
| Q1 2022 | $109,000 | -12.8% | 26,245 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $125,000 | -11.3% | 26,115 | -0.8% | 0.00% | 0.0% |
| Q3 2021 | $141,000 | +5.2% | 26,332 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $134,000 | -28.7% | 26,084 | -6.6% | 0.00% | -50.0% |
| Q1 2021 | $188,000 | +48.0% | 27,934 | +0.5% | 0.00% | +100.0% |
| Q4 2020 | $127,000 | +13.4% | 27,803 | -3.8% | 0.00% | 0.0% |
| Q3 2020 | $112,000 | +19.1% | 28,892 | +46.9% | 0.00% | 0.0% |
| Q2 2020 | $94,000 | +6.8% | 19,673 | -21.9% | 0.00% | -50.0% |
| Q1 2020 | $88,000 | – | 25,185 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 19,552,001 | $433,859,000 | 20.80% |
| BRIDGER MANAGEMENT, LLC | 2,642,621 | $58,640,000 | 3.39% |
| TPG Group Holdings (SBS) Advisors, Inc. | 3,884,600 | $86,199,000 | 1.10% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 125,000 | $2,774,000 | 0.80% |
| HealthCor Management, L.P. | 1,036,110 | $22,991,000 | 0.76% |
| GW&K Investment Management, LLC | 2,049,765 | $45,484,000 | 0.73% |
| Bridge City Capital, LLC | 50,434 | $1,119,000 | 0.70% |
| TCW GROUP INC | 2,521,064 | $55,942,000 | 0.46% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 2,876,367 | $63,827,000 | 0.41% |
| Quadrant Capital Management, LLC | 25,002 | $555,000 | 0.35% |